We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 23, 2016

In re Propranolol Antitrust Litigation

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. April 7, 2017

    Teva, Others Must Face Blood Pressure Drug Antitrust Suit

    Teva, Mylan, Heritage Pharmaceuticals and other generic-drug manufacturers can't dodge antitrust claims accusing them of conspiring to massively increase the price of propranolol hydrochloride, a generic blood pressure medication, a New York federal judge said Thursday.

1 other articles on this case. View all »

Parties

To view the parties, register now.